A new Centers for Disease Control and Prevention report offers guidance on the preexposure use of the JYNNEOS smallpox and monkeypox vaccine for individuals at risk for occupational exposure to orthopoxviruses. The recommendations were made by the CDC’s Advisory Committee on Immunization Practices. The committee recommends preexposure vaccination for people who work in laboratories doing research on orthopoxviruses; people who work in clinical laboratories performing testing to diagnose orthopoxviruses, certain people responding to orthopoxvirus-related public health investigations; and health care personnel who care for patients infected with orthopoxviruses or administer the ACAM2000 vaccine.

Related News Articles

Headline
The AHA Sept. 25 launched its 2023-24 United Against the Flu campaign to help hospitals and health systems encourage their communities to get vaccinated for…
Perspective
Hospitals are places of healing, health and hope. They strive to create safe spaces for the patients and communities they serve and the dedicated team members…
Headline
This season’s flu vaccines for the Southern Hemisphere have reduced the risk of being hospitalized for flu by 52%, based on mid-season data from five countries…
Headline
The Centers for Disease Control and Prevention alerted clinicians, laboratories and public health departments to recent fatal infections from Vibrio…
Headline
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use…
Headline
AHA’s Trustee Services and Hospitals Against Violence teams have released a new brief to raise awareness about violence as a public health issue with hospital…